| Source HCPCS Code |
|
Target NDC Code |
Q9996
Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
|
⇄
|
61314-0651-01
PYZCHIVA 45 MG/0.5 ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
07/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q9996
Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
|
⇄
|
61314-0651-94
PYZCHIVA 45 MG/0.5 ML VIAL
|
| Detail Information |
| Relationship Start Date |
07/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q9996
Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
|
⇄
|
61314-0652-01
PYZCHIVA 90 MG/ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
07/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q9996
Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
|
⇄
|
82009-0160-11
USTEKINUMAB-TTWE 45 MG/0.5 ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
07/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q9996
Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
|
⇄
|
82009-0162-11
USTEKINUMAB-TTWE 90 MG/ML SYR
|
| Detail Information |
| Relationship Start Date |
07/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|